Markets an opioid and synthetic marijuana drug for cancer pain and CINV.
Industry: Health Care
First Day Return: +18.8%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/30/2011 |
Offer Price | $8.00 |
Price Range $8.00 - $10.00 | |
Offer Shares (mm) | 4.0 |
Deal Size ($mm) | $32 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 05/02/2013 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $32 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Phoenix, AZ, United States |
Founded | 1990 |
Employees at IPO | 119 |
Website www.insysrx.com |